Skip to main content

Table 2 Baseline Acute Headache Medication Use in Patients With CMa

From: Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

Medication Use, n (%) Enrolled Population N = 716
Acute headache medication use 639 (89.2)
 Triptans 383 (53.5)
 Simple analgesics 327 (45.7)
 Combination analgesics 225 (31.4)
 Opioids 117 (16.3)
 Ergotamines 53 (7.4)
Acute headache medication overuseb 456 (63.7)
 Triptans (≥10 d) 194 (27.1)
 Combination analgesics (≥10 d) 88 (12.3)
 Simple analgesics (≥15 d) 79 (11.0)
 Opioids (≥10 d) 38 (5.3)
 Ergotamines (≥10 d) 18 (2.5)
  1. CM chronic migraine
  2. aData from patients with ≥20 d of data in their patient diary
  3. bDefinition of medication overuse is based on 4 wk. diary data